Likewise, HER2-enriched breast cancers expressed miR-29b at lower levels and the luminal A-like breast cancers expressed miR-203 at lower levels compared to the other breast cancer subtypes (Table I). This evidence concerns the gene ERBB2 and breast carcinoma.